LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase

Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the RNA binding protein LIN28B as a driver in high-ris...

Full description

Bibliographic Details
Main Authors: Dongdong Chen, Julie Cox, Jayabhargav Annam, Melanie Weingart, Grace Essien, Komal S. Rathi, Jo Lynne Rokita, Priya Khurana, Selma M. Cuya, Kristopher R. Bosse, Adeiye Pilgrim, Daisy Li, Cara Shields, Oskar Laur, John M. Maris, Robert W. Schnepp
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Neoplasia: An International Journal for Oncology Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1476558620301135
id doaj-ad151ae47c9f49dea91c5b91b570dcb8
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Dongdong Chen
Julie Cox
Jayabhargav Annam
Melanie Weingart
Grace Essien
Komal S. Rathi
Jo Lynne Rokita
Priya Khurana
Selma M. Cuya
Kristopher R. Bosse
Adeiye Pilgrim
Daisy Li
Cara Shields
Oskar Laur
John M. Maris
Robert W. Schnepp
spellingShingle Dongdong Chen
Julie Cox
Jayabhargav Annam
Melanie Weingart
Grace Essien
Komal S. Rathi
Jo Lynne Rokita
Priya Khurana
Selma M. Cuya
Kristopher R. Bosse
Adeiye Pilgrim
Daisy Li
Cara Shields
Oskar Laur
John M. Maris
Robert W. Schnepp
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
Neoplasia: An International Journal for Oncology Research
Neuroblastoma
LIN28B
Let-7
PDZ binding kinase
Metastasis
author_facet Dongdong Chen
Julie Cox
Jayabhargav Annam
Melanie Weingart
Grace Essien
Komal S. Rathi
Jo Lynne Rokita
Priya Khurana
Selma M. Cuya
Kristopher R. Bosse
Adeiye Pilgrim
Daisy Li
Cara Shields
Oskar Laur
John M. Maris
Robert W. Schnepp
author_sort Dongdong Chen
title LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
title_short LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
title_full LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
title_fullStr LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
title_full_unstemmed LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
title_sort lin28b promotes neuroblastoma metastasis and regulates pdz binding kinase
publisher Elsevier
series Neoplasia: An International Journal for Oncology Research
issn 1476-5586
publishDate 2020-06-01
description Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the RNA binding protein LIN28B as a driver in high-risk neuroblastoma and demonstrated it promotes oncogenic cell proliferation by coordinating a RAN-Aurora kinase A network. Here, we demonstrate that LIN28B influences another key hallmark of cancer, metastatic dissemination. Using a murine xenograft model of neuroblastoma dissemination, we show that LIN28B promotes metastasis. We demonstrate that this is in part due to the effects of LIN28B on self-renewal and migration, providing an understanding of how LIN28B shapes the metastatic phenotype. Our studies reveal that the let-7 family, which LIN28B inhibits, decreases self-renewal and migration. Next, we identify PDZ Binding Kinase (PBK) as a novel LIN28B target. PBK is a serine/threonine kinase that promotes the proliferation and self-renewal of neural stem cells and serves as an oncogenic driver in multiple aggressive malignancies. We demonstrate that PBK is both a novel direct target of let-7i and that MYCN regulates PBK expression, thus elucidating two oncogenic drivers that converge on PBK. Functionally, PBK promotes self-renewal and migration, phenocopying LIN28B. Taken together, our findings define a role for LIN28B in neuroblastoma metastasis and define the targetable kinase PBK as a potential novel vulnerability in metastatic neuroblastoma.
topic Neuroblastoma
LIN28B
Let-7
PDZ binding kinase
Metastasis
url http://www.sciencedirect.com/science/article/pii/S1476558620301135
work_keys_str_mv AT dongdongchen lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT juliecox lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT jayabhargavannam lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT melanieweingart lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT graceessien lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT komalsrathi lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT jolynnerokita lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT priyakhurana lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT selmamcuya lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT kristopherrbosse lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT adeiyepilgrim lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT daisyli lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT carashields lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT oskarlaur lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT johnmmaris lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
AT robertwschnepp lin28bpromotesneuroblastomametastasisandregulatespdzbindingkinase
_version_ 1724814991664611328
spelling doaj-ad151ae47c9f49dea91c5b91b570dcb82020-11-25T02:33:18ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55862020-06-01226231241LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinaseDongdong Chen0Julie Cox1Jayabhargav Annam2Melanie Weingart3Grace Essien4Komal S. Rathi5Jo Lynne Rokita6Priya Khurana7Selma M. Cuya8Kristopher R. Bosse9Adeiye Pilgrim10Daisy Li11Cara Shields12Oskar Laur13John M. Maris14Robert W. Schnepp15Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USACenter for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USACenter for Data-Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Bioinformatics and Health Informatics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USAEmory Cloning Division EIGC, USADivision of Oncology and Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAAflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Corresponding author at: Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine Health Sciences Research Building, Room E304, 1760 Haygood Drive, Atlanta, GA 30322Neuroblastoma is an aggressive pediatric malignancy of the neural crest with suboptimal cure rates and a striking predilection for widespread metastases, underscoring the need to identify novel therapeutic vulnerabilities. We recently identified the RNA binding protein LIN28B as a driver in high-risk neuroblastoma and demonstrated it promotes oncogenic cell proliferation by coordinating a RAN-Aurora kinase A network. Here, we demonstrate that LIN28B influences another key hallmark of cancer, metastatic dissemination. Using a murine xenograft model of neuroblastoma dissemination, we show that LIN28B promotes metastasis. We demonstrate that this is in part due to the effects of LIN28B on self-renewal and migration, providing an understanding of how LIN28B shapes the metastatic phenotype. Our studies reveal that the let-7 family, which LIN28B inhibits, decreases self-renewal and migration. Next, we identify PDZ Binding Kinase (PBK) as a novel LIN28B target. PBK is a serine/threonine kinase that promotes the proliferation and self-renewal of neural stem cells and serves as an oncogenic driver in multiple aggressive malignancies. We demonstrate that PBK is both a novel direct target of let-7i and that MYCN regulates PBK expression, thus elucidating two oncogenic drivers that converge on PBK. Functionally, PBK promotes self-renewal and migration, phenocopying LIN28B. Taken together, our findings define a role for LIN28B in neuroblastoma metastasis and define the targetable kinase PBK as a potential novel vulnerability in metastatic neuroblastoma.http://www.sciencedirect.com/science/article/pii/S1476558620301135NeuroblastomaLIN28BLet-7PDZ binding kinaseMetastasis